New Food Invest

  • DATABASE (1659)

  • ARTICLES (741)

    • DATABASE (1659)
    • ARTICLES (741)
  • Sort by
    • Relevance
    • Date

NGP Capital was founded in 2005 with Nokia and Bell Labs as its limited partners. It has investment teams in Asia (India and China), North America and Europe. It invests mainly in growth-stage companies with typical investments ranging from $8m–$12m.With more than $1.2bn under management, NGP Capital's portfolio includes Xiaomi, Deliveroo and UCweb. As of July 2019, NGP Capital had invested in more than 90 companies, including eight IPOs and 33 M&As. It focuses also on mobility and digital health sectors.

Josep Ma Moyà is a Barcelona-based angel investor with a consulting background. He invests in and advises locally-based startups in different market segments. To date, he has invested in five startups. The most recent in 2019 was in the €2m seed round of Psquared, Spain’s first flexible workplace management and design company for hybrid workspaces. In 2017, he invested in Kognia Sports Intelligence, an automated software for real-time and post-match football analysis.

As one of the original enterprises of the Japanese Mitsubishi Group, Mitsubishi Motors started its automotive business in the pre-World War era. Mitsubishi Heavy Industries produced and imported cars for local use. The automotive company became part of the Renault-Nissan-Mitsubishi alliance in 2016 after Nissan acquired a controlling stake in Mitsubishi Motors. Indonesia's Gojek is its latest investment to expand into the ride-hailing tech sector in Southeast-Asia.

Crevisse Partners is a South Korean investor and venture builder with an impact focus. Its name stands for “Creative, Visionary and Social Entrepreneurs”. Originally incorporated in 2004, Crevisse claims to be the first impact investor in Korea, even before such terms became commonplace. The company strives to develop businesses in sectors “where the market principle wasn’t working”.Crevisse has internally incubated a number of companies in South Korea, such as reusable drinking cup company BringYourCup, sustainable forestry firm Forest Trust, and fundraising service DONUS. Crevisse Ventures is the company’s dedicated VC arm that manages a $20m fund and a number of blended finance funds through collaborations with government agencies and financial institutions. In particular, Crevisse Ventures focuses on startups that solve problems in four major areas: urban communities; climate and energy; education and welfare; as well as jobs and economic growth.

Schneider Electric is a Europe-based company primarily providing energy management and automation solutions for homes, commercial and industrial-scale properties. The company was originally named Schneider & Cie, founded in 1836 as a metal and weaponry, but between 1975 and 1999 began to refocus towards the electrical industry. The company was renamed Schneider Electric in 1999.Schneider’s technologies focus on managing energy use and conserving energy through a combination of hardware and software. Consequently, Schneider’s investments into startups revolve around the energy sector, with companies like solar power management service Xurya, battery manufacturer Verkor, and building management SaaS Clockworks Analytics as part of their portfolio.

Prosperity7 Ventures is the $1bn diversified VC fund of Aramco Ventures, a subsidiary of Aramco, the world's leading integrated energy and chemicals company. The fund's name derives from “Prosperity Well", the 7th oil well drilled in Saudi Arabia and the first to strike oil. Prosperity7 Ventures invests globally, focusing on highly scalable startups in the US and China.

TI Platform Management is a US-based investment firm founded by Alex Bangash and Trang T Nguyen, who are also the founders of LP network and investment news platform TrustedInsight. Founded in 2015, the firm seeks out disruptive business models and invests in a range of categories, from furniture and home construction to healthcare and deep-tech. It has invested in Singapore-based enzyme engineering startup Allozymes, B2B pharmacy fulfillment service TruePill, and supply chain management startup Tyltgo.

Khosla Ventures is a Silicon Valley-based VC, founded in 2004 by Indian-born founder of tech pioneer Sun Microsystems Vinod Khosla. The company has no specific interest in terms of sector but heavily favors “large problems that are amenable to technology solutions” and invests in so-called high potential  'black swans´. Healthcare is a strong focus and its most recent investments include in the Portuguese home physiotherapy tech solution SWORD Health's 2021 $85m Series C and $25m Series B rounds besides its 2020 $17m Series A round which it led. Khosla has over $5bn under management and more than 70 staff, with investments in more than 700 startups, leading more than one-third. Other recent investments include in the July 2021 $75m Series C round of Indian personal health and fitness app HealthifyMe and, the same month, in the $12.5m Series A round of US commercial real estate app for tenants and property managers Jones. 

Founders Fund is a San Francisco-based VC set up in 2005 that currently has more than $3bn of assets under management. It invests across the tech, aerospace and biotechnology sectors and has been an early backer of some of the most impactful tech companies including Airbnb, Facebook, and SpaceX. It has a key interest in solving major problems such as the opioid crisis in the US.Its recent investments include in the June 2021 $85m Series C round of Portuguese home physiotherapy tech solution SWORD Health, the world’s fastest-growing musculoskeletal solution, and in the July 2021 $80m Series C round of residential real estate platform Sundae. The company has managed over 80 exits including Facebook and Spotify and has made over 500 investments, leading approximately one-third of these. 

Microsoft is a US-based technology company that focuses on software products and services. Its Windows operating system is one of the most widely used in the world, and it is also a leader in the video games industry thanks to its Xbox video game platform. In the corporate world, it is best known for its Azure cloud computing services. It is one of the most valuable companies in the world alongside rival Apple, social media network Facebook, and internet giant Google. Microsoft is an active investor in the technology industry. It invests through its main business entity, as well as through subsidiaries such as M12, formerly known as Microsoft Ventures.

With currently over $21bn of AUM, Baring Private Equity Asia (BPEA) was started in Hong Kong in 1997 by Jean Eric Salata, as the regional Asian PE investment arm of UK-based Baring Private Equity Partners. With $300m in its first fund, it focused on riding China’s economic rise spurred by the country’s market liberalization. In 2000, Salata led a management buyout of BPEA and continues to head the firm today as CEO and Founding Partner. BPEA has invested in more than 100 companies, across healthcare, logistics, IT services, media, education, financial services and retail. It is one of the largest independent PE firms in Asia and has eight offices across the continent.With offices in China, India, Japan, Australia, and Singapore, it currently has around 43 portfolio companies, almost all Asia-based, across multiple business segments in tech and non-tech startups, especially in bricks-and-mortar education establishments. It also makes acquisitions, including most recently of US outsourcing services company Virtusa in February 2021.Other recent investments include in the June 2021 $85m Series C round of Portuguese home physiotherapy tech solution SWORD Health, the world’s fastest-growing musculoskeletal solution, and in the November 2020 $198m Series D round of Chinese computer coding for kids edtech Codemao. 

San Francisco-based BOND is a spinoff of Kleiner Perkins and its original digital growth fund. BOND was launched in 2019, investing across market segments and geographies. To date, it has raised two funds totaling $3.3bn and currently has 32 portfolio companies. Its recent investments include Portuguese home physiotherapy tech SWORD, the world’s fastest-growing musculoskeletal solution, in June 2021 in a $85m Series C funding round; and co-leading the July 2021 $50m Series B round of US fungi-based alt-protein startup Meati Foods. 

Founded in Boston in 2020, General Catalyst backs startups across all market segements at every growth stage, making seed stage investments between $500,000 and $2m. It has backed some of the most successful startups including Airbnb, Stripe and Deliveroo, and, to date, has invested in 243 companies, with 193 in its portfolio currently.  A prolific investor, often making 10 investments or more per month, its most recent investments include in the July 2021 $5m seed round of US medtech, Evvy, designers of a vaginal microbiome test. In the same week, the investor participated in the $150m Series B round of Remote, a Silicon Valley-based platform for remote worker management and administration. 

Founded in Boston in 2019, Transformation is entirely dedicated to healthcare disruption, predominently focuses on US investments and typically invests $10-30m per startup. It currently has 22 companies in its portfolio.  Its most recent investments include in the June 2021 $85m Series C round of Portuguese home physiotherapy tech solution SWORD Health, the world’s fastest-growing musculoskeletal solution, and, the same month, in the $21m Series D round of Protenus, the US’ leading healthcare compliance analytics firm.

Vesalius Biocapital III is a €70 million fund that invests in medtech, e-health initiatives and drug development in Europe. It was launched in 2017 by Luxembourg-based Vesalius Biocapital, a life sciences venture capital firm founded in 2007.  Preceding Vesalius Biocapital III were Vesalius Biocapital I, with €76 million under management and Vesalius Biocapital II, which has €78 million invested; both funds have 11 portfolio companies each.Its recent investments include in Portuguese home physiotherapy tech solution SWORD Health's 2021 $25m Series B and in the 2020 $9m second phase of its Series A round as well as in the 2020 €22m Series B round of German biotech Topas Therapeutics. 

Sorry, we couldn’t find any matches for “New Food Invest”.

Your payment was not successful.

Please make sure you have entered your payment details correctly. Or try again in a few moments.

small logo

The discount code you entered is invalid

Please make sure you have entered your discount code correctly. Or try again in a few moments.

Download successful.

Your sample has been sent. Please check your email.

By accessing and using www.compasslist.com and all pages within the domain (the “Website”), You accept and agree to have read, understood, accepted and agreed to be bound by the Terms of Use and Privacy Policy in full. If you disagree with all or any part of these Terms of Use and Privacy Policy, please do not use or continue any further use of this website. You acknowledge that you are aware that this Website contains an archive of existing content as at 31 December 2021 and is not being actively managed. We are under no obligation to update the content on this Website and, accordingly, no new content or articles will be posted to the Website after 31 December 2021.